{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:07:34Z","timestamp":1778684854054,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40120-026-00926-y","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:51:31Z","timestamp":1774691491000},"page":"1433-1443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatiotemporal Heterogeneity in Isolated Neurosarcoidosis: Diagnostic Insights from Multimodal Imaging"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-0081","authenticated-orcid":false,"given":"Eunmi","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-7779","authenticated-orcid":false,"given":"Hyunjo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-8601","authenticated-orcid":false,"given":"Ji Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"Supplement 6","key":"926_CR1","doi-asserted-by":"publisher","first-page":"S429","DOI":"10.1513\/AnnalsATS.201707-565OT","volume":"14","author":"DR Moller","year":"2017","unstructured":"Moller DR, Rybicki BA, Hamzeh NY, Montgomery CG, Chen ES, Drake W, et al. Genetic, immunologic, and environmental basis of sarcoidosis. Ann Am Thorac Soc. 2017;14(Supplement 6):S429\u201336.","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"926_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.rdc.2017.06.008","volume":"43","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Matteson EL. Neurosarcoidosis. Rheum Dis Clin North Am. 2017;43(4):593\u2013606. https:\/\/doi.org\/10.1016\/j.rdc.2017.06.008.","journal-title":"Rheum Dis Clin North Am"},{"issue":"7","key":"926_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3109\/07853890.2015.1093164","volume":"47","author":"C Tana","year":"2015","unstructured":"Tana C, Wegener S, Borys E, Pambuccian S, Tchernev G, Tana M, et al. Challenges in the diagnosis and treatment of neurosarcoidosis. Ann Med. 2015;47(7):576\u201391. https:\/\/doi.org\/10.3109\/07853890.2015.1093164.","journal-title":"Ann Med"},{"issue":"6","key":"926_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/NRL.0b013e3182704d04","volume":"18","author":"K Nozaki","year":"2012","unstructured":"Nozaki K, Scott TF, Sohn M, Judson MA. Isolated neurosarcoidosis: case series in 2 sarcoidosis centers. Neurologist. 2012;18(6):373\u20137.","journal-title":"Neurologist"},{"key":"926_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s004150170175","volume":"248","author":"DA Nowak","year":"2001","unstructured":"Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol. 2001;248:363\u201372. https:\/\/doi.org\/10.1007\/s004150170175.","journal-title":"J Neurol"},{"issue":"7","key":"926_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11882-023-01092-z","volume":"23","author":"J Shen","year":"2023","unstructured":"Shen J, Lackey E, Shah S. Neurosarcoidosis: diagnostic challenges and mimics a review. Curr Allergy Asthma Rep. 2023;23(7):399\u2013410. https:\/\/doi.org\/10.1007\/s11882-023-01092-z.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"926_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1053\/j.semnuclmed.2013.06.007","volume":"43","author":"D Sobic-Saranovic","year":"2013","unstructured":"Sobic-Saranovic D, Artiko V, Obradovic V. FDG PET imaging in sarcoidosis. Semin Nucl Med. 2013;43(6):404\u201311. https:\/\/doi.org\/10.1053\/j.semnuclmed.2013.06.007.","journal-title":"Semin Nucl Med"},{"key":"926_CR8","doi-asserted-by":"crossref","unstructured":"R\u00e9gis C, Benali K, Rouzet F, editors. FDG PET\/CT imaging of sarcoidosis. In: Seminars in nuclear medicine. Elsevier; 2023.","DOI":"10.1053\/j.semnuclmed.2022.08.004"},{"issue":"12","key":"926_CR9","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","volume":"75","author":"BJ Stern","year":"2018","unstructured":"Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018;75(12):1546\u201353. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2295.","journal-title":"JAMA Neurol"},{"issue":"1","key":"926_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ncl.2009.09.012","volume":"28","author":"BJ Stern","year":"2010","unstructured":"Stern BJ, Aksamit A, Clifford D, Scott TF. Neurologic presentations of sarcoidosis. Neurol Clin. 2010;28(1):185\u201398. https:\/\/doi.org\/10.1016\/j.ncl.2009.09.012.","journal-title":"Neurol Clin"},{"key":"926_CR11","first-page":"1","volume-title":"Neuroimmune diseases: from cells to the living brain","author":"P Ungprasert","year":"2024","unstructured":"Ungprasert P, Moss BP. Neurosarcoidosis. In: Mitoma H, Manto M, editors. Neuroimmune diseases: from cells to the living brain. Cham: Springer International Publishing; 2024. p. 1\u201321."},{"key":"926_CR12","doi-asserted-by":"crossref","unstructured":"Fritz D, Van De Beek D, Brouwer MC, Booij J, editors. Whole-body 18F-FDG PET-CT in the diagnosis of neurosarcoidosis. In: Mayo clinic proceedings; Elsevier; 2020.","DOI":"10.1016\/j.mayocp.2020.01.032"},{"issue":"5","key":"926_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/MCP.0000000000000892","volume":"28","author":"RJ Vender","year":"2022","unstructured":"Vender RJ, Aldahham H, Gupta R. The role of PET in the management of sarcoidosis. Curr Opin Pulm Med. 2022;28(5):485\u201391.","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"926_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030890","volume":"9","author":"RG Keijsers","year":"2020","unstructured":"Keijsers RG, Grutters JC. In which patients with sarcoidosis is FDG PET\/CT indicated? J Clin Med. 2020;9(3):890.","journal-title":"J Clin Med"},{"issue":"2","key":"926_CR15","first-page":"87","volume":"28","author":"G Treglia","year":"2011","unstructured":"Treglia G, Taralli S, Giordano A. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28(2):87\u201394.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"926_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0022-510X(02)00225-3","volume":"205","author":"N Dubey","year":"2002","unstructured":"Dubey N, Miletich RS, Wasay M, Mechtler LL, Bakshi R. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci. 2002;205(1):77\u201381. https:\/\/doi.org\/10.1016\/S0022-510X(02)00225-3.","journal-title":"J Neurol Sci"},{"issue":"10","key":"926_CR17","first-page":"1551","volume":"42","author":"T Mochizuki","year":"2001","unstructured":"Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42(10):1551\u20135.","journal-title":"J Nucl Med"},{"issue":"6","key":"926_CR18","doi-asserted-by":"publisher","first-page":"e1084","DOI":"10.1212\/NXI.0000000000001084","volume":"8","author":"MJ Bradshaw","year":"2021","unstructured":"Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM. Neurosarcoidosis: pathophysiology, diagnosis, and treatment. Neurol Neuroimmunol Neuroinflamm. 2021;8(6):e1084. https:\/\/doi.org\/10.1212\/NXI.0000000000001084.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"926_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.21037\/qims.2019.05.24","volume":"9","author":"WY Yu","year":"2019","unstructured":"Yu WY, Lu PX, Assadi M, Huang XL, Skrahin A, Rosenthal A, et al. Updates on (18)F-FDG-PET\/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring. Quant Imaging Med Surg. 2019;9(6):1132\u201346. https:\/\/doi.org\/10.21037\/qims.2019.05.24.","journal-title":"Quant Imaging Med Surg"},{"issue":"9","key":"926_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/qjmed\/hcy128","volume":"111","author":"B Leroy-Freschini","year":"2018","unstructured":"Leroy-Freschini B, Treglia G, Argemi X, Bund C, Kessler R, Herbrecht R, et al. 18F-FDG PET\/CT for invasive fungal infection in immunocompromised patients. QJM. 2018;111(9):613\u201322. https:\/\/doi.org\/10.1093\/qjmed\/hcy128.","journal-title":"QJM"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-00926-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:08:08Z","timestamp":1778681288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-00926-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-00926-y","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eunmi Lee has nothing to disclose. Hyunjo Lee has nothing to disclose. Ji Hye Kim has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. This case report was reviewed and approved by the Institutional Review Board of the Ulsan University Hospital (IRB no. 2025\u201305-010). Due to the retrospective nature of the study based on medical record review, informed consent to participate was waived by the ethics committee. Written informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}